Deals in brief – December 2018/January 2019

0
1802
blue star

ACTIS EXITS SYMBIOTEC STAKE

A consortium of private equity funds formed by Motilal Oswal Private Equity and Invascent bought out the entire stake of private equity investor Actis in drugmaker Symbiotec Pharmalab. The Indore, India-based Symbiotec Pharmalab is one of the largest steroids/hormones companies globally and a leading active pharmaceutical ingredient (API) manufacturer. Actis had invested US$48 million in Symbiotec in 2013. The incoming private equity investors have committed further primary investments in the company.

L&L Partners advised the promoters of Symbiotec. The L&L team was led by partner William Vivian John along with managing associate Deepak Kumar and associate Tanaya Sanyal.

SAPPHIRE RAISES US$31 MILLION

Sapphire Foods, the South Asian franchisee of Yum! Brands, raised ₹2.25 billion (US$31 million) in equity investment in a round led by Edelweiss Private Equity and existing investor Goldman Sachs. The investors picked up about a 10% stake in this round of investment. Sapphire Foods was founded in September 2015 by a consortium of private equity firms –Samara Capital, Goldman Sachs, CX Partners and IDI Emerging. The company acquired about 250 KFC and Pizza Hut restaurants in India and Sri Lanka from multiple franchisees and Yum Restaurants India. In total it operates more than 350 KFC, Pizza Hut and Taco Bell restaurants in India, Sri Lanka and the Maldives.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们